Gilead aims to license hepatitis C drug to 3-4 Indian firms WTAQ We're nailing down the geographical scope, and we should have these licenses in place and ready to go in short order," Samuel said on a visit to London for an international liver conference. He said Gilead was looking to strike deals with firms that ... |
